NorthStrive Biosciences Files New U.S. Patent Application for EL-22 Targeting Muscle Preservation in Humans

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. ACN
3. NVDA
4. USO
5. GOOGL
6. APGE
7. DFTX
8. MU
9. HOOD
10. RGNX

Go back to NorthStrive Biosciences Files New U.S. Patent Application for EL-22 Targeting Muscle Preservation in Humans
(NASDAQ: ELAB) Delayed: 1.37 -0.02 (1.44%)
Previous Close $1.39    52 Week High $ 
Open $1.38    52 Week Low $ 
Day High $1.41    P/E N/A 
Day Low $1.34    EPS $ 
Volume 254,993